Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The organic components of dentine and local oral tissues represent a heterogeneous collection of proteins and molecules that form the extracellular matrix (ECM). Approximately 90% of the dentine organic matrix is composed of Type I collagen, which provides a scaffold for hydroxyapatite crystal deposition, while the remaining 10% consists of non-collagenous proteins (NCPs) like dentin sialophosphoprotein (DSPP) and proteoglycans that regulate mineralization [1][2]. These components are crucial in the pathogenesis of dental caries, where bacterial acids demineralize the inorganic phase, exposing the organic matrix to degradation by host-derived enzymes like matrix metalloproteinases (MMPs) [3]. Therapeutic interventions often target these components to improve dental bonding or treat sensitivity; for example, glutaraldehyde is used to coagulate proteins within dentinal tubules to block fluid movement, and chlorhexidine is applied to inhibit MMPs and preserve the integrity of the resin-dentine interface [4][5]. Understanding the interaction between dental materials and these organic components is essential for developing durable restorative treatments and promoting tissue regeneration. [1] Goldberg, M., et al. (2011). Dentine: a dynamic tissue. [2] Linde, A. (1989). Dentin matrix proteins: composition and possible functions. [3] Tjäderhane, L., et al. (2015). The role of host-derived ethylenediaminetetraacetic acid-soluble proteins in dentine caries. [4] Qin, X., et al. (2014). Effect of glutaraldehyde on the collagen stability. [5] Pashley, D. H., et al. (2004). Collagen degradation by host-derived enzymes during aging.
Drugs interact with these components through protein coagulation, cross-linking, enzymatic inhibition of matrix metalloproteinases (MMPs), or chemical hybridization to stabilize the dentine-pulp complex and facilitate dental adhesion.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Other exposed proteins and organic components in dentine and local oral tissues.